cross country healthcare, headquartered in boca raton, florida, is a national leader in providing leading-edge healthcare workforce solutions. our solutions are geared towards assisting our clients to solve labor cost issues while maintaining high quality outcomes. with more than 30 years of experience, we are dedicated to placing highly qualified nurses and physicians as well as allied health, advanced practice, and case management professionals. we also provide both retained and contingent placement services for physicians, as well as retained search services for healthcare executives. we have more than 6,500 active contracts with a broad range of clients in both clinical and nonclinical settings, including acute care hospitals, physician practice groups, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and home care. through our national staffing teams and network of more than 70 branch office locations,
Company profile
Ticker
CCRN
Exchange
Website
CEO
Kevin Clark
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CROSS COUNTRY INC
SEC CIK
Corporate docs
Subsidiaries
Assignment America, LLC • Cejka Search, LLC • Credent Verification and Licensing • Cross Country DAS, Inc. • Cross Country Holdco (Cyprus) Limited • Cross Country Infotech, Pvt. Ltd. • Cross Country Staffing, Inc. • Cross Country Tech, LLC • Intellify Talent Solutions, LLC • Medical Doctor Associates, LLC ...
IRS number
134066229
CCRN stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
10 Apr 24
DEFR14A
Revised proxy
4 Apr 24
ARS
2023 FY
Annual report to shareholders
1 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
8-K
Cross Country Healthcare to Attend the Oppenheimer 34TH Annual Healthcare Conference
23 Feb 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Departure of Directors or Certain Officers
21 Feb 24
8-K
Cross Country Healthcare Announces Fourth Quarter and Full Year
21 Feb 24
8-K
Regulation FD Disclosure
1 Feb 24
Transcripts
CCRN
Earnings call transcript
2023 Q3
1 Nov 23
CCRN
Earnings call transcript
2023 Q2
2 Aug 23
CCRN
Earnings call transcript
2023 Q1
3 May 23
CCRN
Earnings call transcript
2022 Q4
22 Feb 23
CCRN
Earnings call transcript
2022 Q3
2 Nov 22
CCRN
Earnings call transcript
2022 Q2
4 Aug 22
CCRN
Earnings call transcript
2022 Q1
5 May 22
CCRN
Earnings call transcript
2021 Q4
24 Feb 22
CCRN
Earnings call transcript
2021 Q3
4 Nov 21
CCRN
Earnings call transcript
2021 Q2
8 Aug 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 14.30 mm | 14.30 mm | 14.30 mm | 14.30 mm | 14.30 mm | 14.30 mm |
Cash burn (monthly) | (no burn) | 1.33 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 9.14 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 5.16 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 3.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 186 |
Opened positions | 23 |
Closed positions | 30 |
Increased positions | 71 |
Reduced positions | 66 |
13F shares | Current |
---|---|
Total value | 899.93 bn |
Total shares | 37.06 mm |
Total puts | 27.70 k |
Total calls | 89.90 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 5.60 mm | $138.82 bn |
Vanguard | 2.46 mm | $61.02 bn |
Dimensional Fund Advisors | 2.18 mm | $54.04 bn |
PFG Principal Financial Group Inc - Registered Shares | 1.97 mm | $48.74 bn |
Systematic Financial Management | 1.85 mm | $45.96 bn |
Wellington Management | 1.75 mm | $43.34 bn |
Pacer Advisors | 1.65 mm | $41.02 bn |
STT State Street | 1.29 mm | $32.02 bn |
Wasatch Advisors | 1.26 mm | $31.20 bn |
MS Morgan Stanley | 1.06 mm | $26.35 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 24 | Daniel Joseph White | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 1,254 | 23.47 k | 15,255 |
31 Mar 24 | Daniel Joseph White | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 1,059 | 19.82 k | 16,509 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 441 | 8.26 k | 24,234 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 454 | 8.50 k | 24,675 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 887 | 16.60 k | 25,129 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 1,642 | 30.74 k | 26,016 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Grant | Acquire A | No | No | 0 | 1,603 | 0.00 | 27,658 |
31 Mar 24 | Colin Patrick McDonald | Common Stock | Grant | Acquire A | No | No | 0 | 4,808 | 0.00 | 26,055 |
31 Mar 24 | James V. Redd III | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 392 | 7.34 k | 18,441 |
31 Mar 24 | James V. Redd III | Common Stock | Payment of exercise | Dispose F | No | No | 18.72 | 308 | 5.77 k | 18,833 |
News
Barrington Research Maintains Outperform on Cross Country Healthcare, Lowers Price Target to $24
27 Feb 24
4 Analysts Have This To Say About Cross Country Healthcare
22 Feb 24
Truist Securities Maintains Hold on Cross Country Healthcare, Lowers Price Target to $16
22 Feb 24
Benchmark Maintains Buy on Cross Country Healthcare, Lowers Price Target to $21
22 Feb 24
Cross Country Healthcare Sees Q1 EPS $0.15-$0.25 Vs $0.30 Est.; Revenue $370M-$380M Vs $399.04M Est.
21 Feb 24
Press releases
Cross Country EVP, Chief Administrative Officer and General Counsel Named to Global Top 50 Corporate Counsel List
24 Apr 24
Cross Country Healthcare to Hold First Quarter 2024 Earnings Conference Call on Wednesday, May 1, 2024
10 Apr 24
Cross Country Healthcare to Attend the Oppenheimer 34th Annual Healthcare Conference
23 Feb 24
Cross Country CEO Featured on 2024 Staffing Industry Analysts' 100 in Staffing List
22 Feb 24
Cross Country Healthcare Announces Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24